Novo Nordisk is bringing Anthropic’s Claude into the drug discovery pipeline. The company plans to test Claude Science across research and development workflows, using AI to help scientists reason through complex problems, design targeted workflows and accelerate the path toward new medicines. This is the larger shift to watch: AI is moving deeper into the machinery of scientific discovery, not just the business side of healthcare. #MacroSift #Anthropic #Claude #DrugDiscovery #Biotech